One of the issue I have with the cord blood storage model is that the margins would be slim as more an more companies got into this biz. Not to mention stem cell tech is changing and storage will be obsolute when adult cells can be manipulted enough to perform as stem cells. Public stem cell banking has endorsement and funding which slices the pie even more. The article I am posting can be looked as a positive or a negative for CBAI. You decide.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.